Orbimed Asia III Mauritius FVCI Ltd's Insider Trades & SAST Disclosures
No reported Insider Trades available for Orbimed Asia III Mauritius FVCI Ltd in the Trendlyne database.
Orbimed Asia III Mauritius FVCI Ltd's has made SAST transactions in Advanced Enzyme Technologies Ltd. recently where a Acquisition of 11,053,245 shares done . Disclosure was reported to the exchange on June 21, 2024.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Advanced Enzyme | Orbimed Asia III Mauritius FVCI Ltd | Other | Acquisition | 04 Jul 2024 | 11,053,245 | 13,509,522 | - | - | 20 Jun 2024 20 Jun 2024 |
SAST (29(2)) | - | Market | |
| Advanced Enzyme | Orbimed ASIA III Mauritius FVCI Ltd | Other | Acquisition | 04 Jul 2024 | 11,053,245 | 13,509,522 | - | - | 20 Jun 2024 20 Jun 2024 |
SAST (29(1)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.